These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21996204)

  • 1. Iron metabolism in kidney allograft recipients: still a mystery?
    Malyszko J; Głowińska I; Malyszko JS; Levin-Iaina N; Koc-Zorawska E; Mysliwiec M
    Transplant Proc; 2011 Oct; 43(8):2973-5. PubMed ID: 21996204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron metabolism in hemodialyzed patients - a story half told?
    Malyszko J; Koc-Zorawska E; Levin-Iaina N; Slotki I; Matuszkiewicz-Rowinska J; Glowinska I; Malyszko JS
    Arch Med Sci; 2014 Dec; 10(6):1117-22. PubMed ID: 25624847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of non-transferrin-bound iron in heart transplant recipients.
    Przybylowski P; Malyszko J; Levin-Iaina N; Malyszko JS
    Transplant Proc; 2011 Oct; 43(8):3068-70. PubMed ID: 21996227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.
    Breuer W; Ghoti H; Shattat A; Goldfarb A; Koren A; Levin C; Rachmilewitz E; Cabantchik ZI
    Am J Hematol; 2012 Jan; 87(1):55-61. PubMed ID: 22125177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
    Taher A; Musallam KM; El Rassi F; Duca L; Inati A; Koussa S; Cappellini MD
    Br J Haematol; 2009 Sep; 146(5):569-72. PubMed ID: 19604239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontransferrin-bound iron in transfused patients with sickle cell disease.
    Inati A; Musallam KM; Cappellini MD; Duca L; Taher AT
    Int J Lab Hematol; 2011 Apr; 33(2):133-7. PubMed ID: 21382180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of iron deficiency in heart and kidney allograft recipients.
    Przybylowski P; Malyszko J; Glowinska I; Malyszko J; Kozlowska S; Mysliwiec M
    Transplant Proc; 2011 Dec; 43(10):3885-7. PubMed ID: 22172865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
    Pai AB; Conner T; McQuade CR; Olp J; Hicks P
    Biometals; 2011 Aug; 24(4):603-13. PubMed ID: 21229380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
    Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
    Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy Guatemalan males.
    Schümann K; Kroll S; Romero-Abal ME; Georgiou NA; Marx JJ; Weiss G; Solomons NW
    Ann Nutr Metab; 2012; 60(2):98-107. PubMed ID: 22398912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPI-labile plasma iron in iron overload.
    Cabantchik ZI; Breuer W; Zanninelli G; Cianciulli P
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):277-87. PubMed ID: 15737890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
    Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common presence of non-transferrin-bound iron among patients with type 2 diabetes.
    Lee DH; Liu DY; Jacobs DR; Shin HR; Song K; Lee IK; Kim B; Hider RC
    Diabetes Care; 2006 May; 29(5):1090-5. PubMed ID: 16644642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-transferrin bound iron: a key role in iron overload and iron toxicity.
    Brissot P; Ropert M; Le Lan C; Loréal O
    Biochim Biophys Acta; 2012 Mar; 1820(3):403-10. PubMed ID: 21855608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.